Log in

Wize Pharma Stock Forecast, Price & News

0.00 (0.00 %)
(As of 09/21/2020 12:00 AM ET)
Today's Range
Now: $0.20
50-Day Range
MA: $0.19
52-Week Range
Now: $0.20
Average Volume20,299 shs
Market Capitalization$3.26 million
P/E RatioN/A
Dividend YieldN/A
Wize Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the treatment of ophthalmic disorders. It has in-license rights to purchase, market, sell, and distribute LO2A for the treatment of dry eye syndrome (DES)and other ophthalmological illnesses, including Conjunctivochalasis (CCH) and Sjögren's syndrome (Sjögren's) in the United States, Israel, Ukraine, and China. The company markets LO2A products for the treatment of DES in Germany and Switzerland; DES and CCH in Hungary; and DES and Sjögren's in the Netherlands. It is developing LO2A, which is in Phase II trial for patients with CCH; and Phase IV study for DES in patients with Sjögren's. The company was formerly known as Star Night Technologies Ltd. and changed its name to Wize Pharma, Inc. in July 2015. Wize Pharma, Inc. was founded in 1982 and is headquartered in Hod Hasharon, Israel.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.60 out of 5 stars

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolOTCMKTS:WIZP



Sales & Book Value

Annual SalesN/A
Book Value$0.03 per share


Net Income$-3,450,000.00


Market Cap$3.26 million
Next Earnings Date11/12/2020 (Estimated)
OptionableNot Optionable
0.00 (0.00 %)
(As of 09/21/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive WIZP News and Ratings via Email

Sign-up to receive the latest news and ratings for WIZP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Wize Pharma (OTCMKTS:WIZP) Frequently Asked Questions

How has Wize Pharma's stock been impacted by COVID-19?

Wize Pharma's stock was trading at $0.2296 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, WIZP stock has decreased by 12.9% and is now trading at $0.20.
View which stocks have been most impacted by COVID-19

When is Wize Pharma's next earnings date?

Wize Pharma is scheduled to release its next quarterly earnings announcement on Thursday, November 12th 2020.
View our earnings forecast for Wize Pharma

Who are some of Wize Pharma's key competitors?

What other stocks do shareholders of Wize Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Wize Pharma investors own include Neos Therapeutics (NEOS), Verastem (VSTM), Cara Therapeutics (CARA), Canopy Growth (CGC), Charlotte's Web (CWBHF), Intellicheck (IDN), Magic Software Enterprises (MGIC), Pure Bioscience (PURE), Sesen Bio (SESN) and Spero Therapeutics (SPRO).

Who are Wize Pharma's key executives?

Wize Pharma's management team includes the following people:
  • Mr. Or Eisenberg, Acting CEO, CFO, Treasurer & Sec. (Age 38)
  • Mr. Noam Danenberg, Chief Operating Officer (Age 49)

What is Wize Pharma's stock symbol?

Wize Pharma trades on the OTCMKTS under the ticker symbol "WIZP."

How do I buy shares of Wize Pharma?

Shares of WIZP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Wize Pharma's stock price today?

One share of WIZP stock can currently be purchased for approximately $0.20.

How big of a company is Wize Pharma?

Wize Pharma has a market capitalization of $3.26 million. The company earns $-3,450,000.00 in net income (profit) each year or ($0.37) on an earnings per share basis. Wize Pharma employs 1 workers across the globe.

What is Wize Pharma's official website?

The official website for Wize Pharma is www.wizepharma.com.

How can I contact Wize Pharma?

Wize Pharma's mailing address is 24 HANAGAR STREET, HOD HASHARON L3, 4527708. The company can be reached via phone at 972-72-260-0536.

This page was last updated on 9/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.